Filter
926
Filtered Results: 926
Text search:
Pan
American
Health
Organization
(PAHO)
Featured
Recommendations
79
New Publications
154
Language
Document type
No document type
280
Studies & Reports
189
Guidelines
160
Manuals
73
Fact sheets
55
Strategic & Response Plan
47
Infographics
27
Training Material
25
Situation Updates
21
Resource Platforms
20
Videos
12
Brochures
8
Dashboards/Maps
5
Online Courses
4
Countries / Regions
Latin America and the Carribbean
228
Brazil
65
Global
57
Mozambique
23
Paraguay
23
Venezuela
22
Angola
22
North America
21
Colombia
19
Haiti
18
Guinea-Bissau
10
Argentina
9
Peru
7
Bolivia
7
Chile
4
Asia
4
Ecuador
4
Ukraine
3
Africa
3
Bangladesh
3
Russia
3
Myanmar / Burma
3
Mexico
2
Ghana
2
Syria
2
West and Central Africa
2
South–East Asia Region
2
Jamaica
2
Portugal
2
East and Southern Africa
2
Eastern Europe
2
Yemen
2
Zambia
2
Tajikistan
1
Nepal
1
El Salvador
1
Lesotho
1
Benin
1
China
1
Iran
1
Nigeria
1
Laos
1
Estonia
1
Cambodia
1
Dominican Republic
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Uruguay
1
Japan
1
Spain
1
Vietnam
1
Moldova
1
Honduras
1
Bahamas
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
275
Clinical Guidelines
93
Public Health
72
Key Resources
62
Women & Child Health
55
Capacity Building
18
Pharmacy & Technologies
15
Annual Report MEDBOX
1
Toolboxes
COVID-19
221
NTDs
82
Mental Health
73
Rapid Response
59
Zika
49
Planetary Health
38
HIV
37
NCDs
37
TB
29
Caregiver
24
Natural Hazards
18
Global Health Education
18
AMR
17
Cholera
12
Malaria
12
Pharmacy
11
Refugee
9
Health Financing Toolbox
9
Conflict
8
Disability
6
Specific Hazards
5
Ebola & Marburg
4
Polio
2
Typhoon
2
Social Ethics
1
Esta quarta edição do manual se baseia no esquema de avaliação de risco apresentado na terceira edição. Uma avaliação completa, baseada em evidências e transparente dos riscos permite que as medidas de segurança sejam equilibradas com o risco real de trabalhar com agentes biológicos, caso...
Meeting Report
Bangkok, Thailand 8-11 August 2016
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Methodological field approaches for scientists with a basic background in entomology to prepare and implement a yellow fever entomological assessment during outbreaks
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
Доклад Секретариата по теме Деменция
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that may exist at any one of three stages: CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. Instead of screening and diagnosis by the standard sequence of cytolo...
Second editon
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
